TY - JOUR
T1 - Recommendations on intervention for hepatobiliary oncological surgery during the COVID-19 pandemic
AU - Grupo colaborativo Cirugía-AEC-COVID-19
AU - Grupo colaborativo Cirugía-AEC-COVID-19
AU - García Botella, Alejandra
AU - Gómez Bravo, Miguel Angel
AU - Di Martino, Marcello
AU - Gastaca, Mikel
AU - Martín-Pérez, Elena
AU - Sánchez Cabús, Santiago
AU - Sánchez Pérez, Belinda
AU - López Ben, Santiago
AU - Rodríguez Sanjuán, Juan Carlos
AU - López-Andújar, Rafael
AU - Barrera, Manuel
AU - Balibrea, Jose M.
AU - Rubio-Pérez, Inés
AU - Badia, Josep M.
AU - Martin-Antona, Esteban
AU - Álvarez Peña, Estibaliz
AU - Garcia-Botella, A.
AU - Álvarez Gallego, Mario
AU - Martínez Cortijo, Sagrario
AU - Pascual Migueláñez, Isabel
AU - Pérez Díaz, Lola
AU - Ramos Rodríquez, José Luis
AU - Espín-Basany, Eloy
AU - Sánchez Santos, Raquel
AU - Guirao Garriga, Xavier
AU - Aranda Narváez, José Manuel
AU - Morales-Conde, Salvador
N1 - Publisher Copyright:
© 2020 AEC
PY - 2021/3
Y1 - 2021/3
N2 - The SARS-CoV-2 (COVID-19) pandemic requires an analysis in the field of oncological surgery, both on the risk of infection, with very relevant clinical consequences, and on the need to generate plans to minimize the impact on possible restrictions on health resources. The AEC is making a proposal for the management of patients with hepatopancreatobiliary (HPB) malignancies in the different pandemic scenarios in order to offer the maximum benefit to patients, minimising the risks of COVID-19 infection, and optimising the healthcare resources available at any time. This requires the coordination of the different treatment options between the departments involved in the management of these patients: medical oncology, radiotherapy oncology, surgery, anaesthesia, radiology, endoscopy department and intensive care. The goal is offer effective treatments, adapted to the available resources, without compromising patients and healthcare professionals safety.
AB - The SARS-CoV-2 (COVID-19) pandemic requires an analysis in the field of oncological surgery, both on the risk of infection, with very relevant clinical consequences, and on the need to generate plans to minimize the impact on possible restrictions on health resources. The AEC is making a proposal for the management of patients with hepatopancreatobiliary (HPB) malignancies in the different pandemic scenarios in order to offer the maximum benefit to patients, minimising the risks of COVID-19 infection, and optimising the healthcare resources available at any time. This requires the coordination of the different treatment options between the departments involved in the management of these patients: medical oncology, radiotherapy oncology, surgery, anaesthesia, radiology, endoscopy department and intensive care. The goal is offer effective treatments, adapted to the available resources, without compromising patients and healthcare professionals safety.
KW - COVID-19 infection
KW - Cancer
KW - Oncological surgery
KW - Pandemic
UR - https://www.scopus.com/pages/publications/85099509651
U2 - 10.1016/j.ciresp.2020.10.010
DO - 10.1016/j.ciresp.2020.10.010
M3 - Article
SN - 0009-739X
VL - 99
SP - 174
EP - 182
JO - Cirugia Espanola
JF - Cirugia Espanola
IS - 3
ER -
